ArticleMethods (San Diego, Calif.)2021

Bisindolylmaleimide IX: A novel anti-SARS-CoV2 agent targeting viral main protease 3CLpro demonstrated by virtual screening pipeline and in-vitro validation assays.

Yash Gupta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.